Tag Archives: bad-request

Achillion, J&J To Jointly Develop Hepatitis C Drugs

Small biotech Achillion Pharmaceuticals (ACHN) announced late Tuesday that it had entered a collaboration with Johnson & Johnson (JNJ) to develop its hepatitis C drugs, potentially worth more than $1 billion. J&J agreed to invest $225 million in Achillion upfront, and promised up to $1.1 billion in development, regulatory and sales milestone payments if the companies successfully launch their pipeline of drugs treating the hepatitis C virus (HCV).

Take-Two up on Q4 earnings, but game slate ‘underwhelming’

Take-Two Interactive Software (TTWO), maker of the hit pro basketball video game “NBA 2K15,” delivered a slam dunk Monday for its fiscal fourth-quarter earnings. Take-Two stock rose 18% to 28.62 on the stock market today. The game publisher, best known for its “Grand Theft Auto” series, hit a record high of 30.80 on Jan. 28. For the quarter ended March 31, Take-Two earned 49 cents a share excluding items, up 133% year over year and beating Wall Street’s target of 27 cents. Sales rose 83% to $428 million, short of the $459 million expected by analysts polled by Thomson Reuters. Under generally accepted accounting principles (GAAP), Take-Two lost $2.99 a share in Q4, vs. a year-earlier profit of 40 cents a share. GAAP sales rose 54% to $300 million.

Shopify Attracts More Shoppers Anxious For Its IPO

Shopify increased the expected price of its upcoming IPO, indicating strong demand for shares of the provider of e-commerce services for small to medium-sized businesses. Shopify raised its offering price to a range of 14 to 16 a share, from 12 to 14. At the midpoint, Shopify would raise nearly $116 million by selling 7.7 million shares and have a valuation above $1 billion. The initial public offering is set to price late Wednesday and begin